Facilitating Innovative Nuclear Diagnostics Act of 2023

Cost and committee reports

Official records Congress.gov attaches to H.R. 1199.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. DUNN of Florida, as printed in the Congressional Record (Vol. 169, No. 37, February 27, 2023, Page H916):
  Article 1, Section 8, Clause 3 The single subject of this legislation is: Medicare reimbursement for diagnostic radiopharmaceuticals
  Source: Congress.gov, Congressional Record February 27, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  132 characters

  Congress.gov bill record

  H.R. 1199, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/1199

  Record last updated by Congress.gov

  December 5, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  ea6d2b01f5ddc9591e77a27bdc30569361b5affbd5ec95007352d83eda756365

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of December 5, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 1199, last updated December 5, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.